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A thorough understanding of the epidemiology, patient characteristics, trauma mechanisms, 
and current outcomes among patients with severe traumatic brain injury (TBI) is important as 












study is to describe the prehospital epidemiology, characteristics and outcome of (suspected) 
severe TBI in the Netherlands. 
Methods 
The BRAIN-PROTECT study is a prospective observational study on prehospital 
management of patients with severe TBI in the Netherlands. The study population comprised 
all consecutive patients with clinical suspicion of TBI and a prehospital GCS score ≤ 8, who 
were managed by one of the 4 Helicopter Emergency Medical Services (HEMS). Patients 
were followed-up in 9 trauma centers until 1 year after injury. Planned sub-analyses were 
performed for patients with “confirmed” and “isolated” TBI.  
Results 
Data from 2,589 patients, of whom 2,117 (81.8%) were transferred to a participating trauma 
center, were analyzed. The incidence rate of prehospitally suspected and confirmed severe 
TBI were 3.2 (95% CI: 3.1;3.4) and 2.7 (95% CI: 2.5;2.8) per 100,000 inhabitants per year, 
respectively. Median patient age was 46 years, 58.4% were involved in traffic crashes, of 
which 37.4% were bicycle related. 47.6% presented with an initial GCS of 3. The median 
time from HEMS dispatch to hospital arrival was 54 minutes. The overall 30-day mortality 
was 39.0% (95% CI: 36.8;41.2).  
Conclusion 
This article summarizes the prehospital epidemiology, characteristics and outcome of severe 
TBI in the Netherlands, and highlights areas in which primary prevention and prehospital care 
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Introduction 
Traumatic Brain Injury (TBI) is associated with high mortality rates and limited functional 
recovery among survivors (1-3). Treatment of TBI, long-term rehabilitation and costs 
associated with loss of productive life years impose a great financial burden on society (4, 5). 
Reducing morbidity and mortality of the patients affected most heavily – those suffering from 
severe TBI – is of great benefit for individual patients as well as society.  
Most of the previous studies on severe TBI focus on intra-hospital treatment and recovery 
after hospitalization (6, 7). Patients with TBI are, however, at risk of developing secondary 
brain injury before they even reach the hospital, therefore management during the period 
immediately following the initial trauma, i.e., the prehospital period, is of great importance in 
the modification of patients’ outcome (8).  
There is broad consensus that prehospital treatment strategies should aim to prevent and treat 
factors that are known to trigger secondary brain injuries, such as hypoxia, hypotension, as 
well as hypo- and hyperventilation. However, it is less clear how this can best be achieved. 
Guidelines for prehospital treatment are rather vague and are based on low quality evidence 
(9). The prehospital treatment of severe TBI is therefore often opinion based rather than 
evidence based and resembles a “black box”, in which the effects of treatments on outcomes 













To address these knowledge gaps, a large-scale prospective multicenter study on prehospital 
treatment of severe TBI was initiated in the Netherlands: the BRAIN-PROTECT study (8). A 
first step in identifying beneficial treatment strategies, optimal prehospital care and effective 
primary prevention is a thorough understanding of the patient population being treated in the 
context of the involved Emergency Medical System. The aim of this study is to describe the 
epidemiology, patient characteristics, operational characteristics, trauma mechanisms, and 
outcomes of patients with (suspected) severe TBI in the Netherlands.  
Methods 
Study design and setting 
The BRAIN-PROTECT study is a prospective observational study perfomed on the 
prehospital treatment of patients with suspected severe TBI in the Netherlands. A detailed 
description of the methodology has been published previously (8). Briefly, in the Netherlands, 
prehospital trauma care is provided by regional ambulance services as well as 4 physician-
staffed Helicopter Emergency Medical Services (HEMS) located in Amsterdam, Rotterdam, 
Nijmegen, and Groningen. HEMS have the option to respond to trauma incidents with a 
modified ambulance vehicle instead of helicopter if required due to operational, technical or 
meteorological reasons.  
Commonly two ambulance vehicles and one HEMS team are dispatched to major trauma 
incidents including suspected severe TBI. Only in exceptional cases, e.g., unavailability of a 












HEMS is not involved in the prehospital treatment of patients with severe TBI. Patients with 
suspected TBI were transferred to specialized traumacenters, of which 9 participated in this 
study (Amsterdam UMC, location VUmc (Amsterdam), Erasmus MC (Rotterdam), Radboud 
UMC (Nijmegen), UMC Groningen (Groningen), Isala (Zwolle), Medisch Spectrum Twente 
(Enschede), Elisabeth-TweeSteden Ziekenhuis (Tilburg), NoordWest Ziekenhuisgroep 
(Alkmaar), UMC Utrecht (Utrecht)). Ongoing care and follow-up was the responsibility of 
these centers.  
 
The Medical Research Ethics Committees of the Amsterdam University Medical Center, 
location VUmc (reference number 2012/041) and Erasmus MC Rotterdam (reference number 
MEC-2012-515) reviewed the study protocol and concluded that the research is not subject to 
the Dutch Medical Research Involving Human Subjects Act. Patient consent was waved as 
described previously (8). This report adheres to the Strengthening the Reporting of 
Observational studies in Epidemiology (STROBE) guidelines (10). 
 
Selection of Participants  
The four HEMS teams prospectively recorded data on all patients with a clinical suspicion of 
severe TBI, based on a trauma mechanism or clinical findings suggestive for TBI in 
combination with a prehospital Glasgow Coma Scale (GCS) score ≤ 8. Data from all 
consecutive patients meeting the predefined criteria and who were transported to a hospital for 












rather than confirmed – TBI as the prehospital treatment was based on the clinical suspicion 
rather than on the definitive diagnosis. This study focussed on severe TBI, because these 
patients are considerd at high risk for impairments of vital functions and secondary brain 
injury, may markedly differ from patients with less severe TBI regarding benefit/harm of 
interventions, and might particularly profit from optimal prehospital treatment strategies (8). 
The inclusion period began on February 12
th
 2012 with a phased approach across the 
participating HEMS and lasted until December 31
st
 2017. Patients were followed up in 
participating trauma centers for in-hospital data and outcome data until 1 year after inclusion, 
i.e., up to December 2018. 
 
For planned subgroup analyses, patients were further stratified into “confirmed TBI” and 
“isolated TBI”. Patients were characterized as confirmed TBI if the Head Abbreviated Injury 
Score (H-AIS) was 3 or more. Isolated TBI was characterized as a H-AIS ≥3, with Neck, 
Spine, Thorax, Abdomen and Extremities AIS ≤2. 
 
Measurements 
Data collection was based on the Utstein template for uniform reporting of data following 
major trauma (11). Prehospital data, including operational data, mechanism of injury, clinical 
findings, vital parameters and treatments, were prospectively collected by the four HEMS, 












collected by a trained data manager. The published study protocol contains a more detailed 
overview of the measured and collected variables (8).  
 
Outcomes 
The primary outcome parameter was mortality at 30 days. Secondary outcomes included 1-
year survival, and functional outcome assessed with the Glasgow Outcome Scale (GOS) at 
hospital discharge and the Glasgow Outcome Scale – Extended (GOS-E) at 1 year ((10–14 
months), as also described in detail in the study protocol (8).   
Analysis 
Descriptive statistics were used for demographic data, injury characteristics, and outcome 
data. These included means and standard deviations, medians and quartiles, or numbers and 
percentages as appropriate (12). Denominators were reported for the percentages whenever 
the calculation was based on less than the total number of patients (e.g., for subgroup analyses 
or due to missing data). Estimates of population parameters were accompanied by 95% 
confidence intervals (CI) (13). A Kaplan-Meier survivor function was used to describe 
survival over time (14). Three separate logistic regression models were fit to model the 
unadjusted relationship between age, initial GCS as well as Injury Severity Score (ISS) and 
the logit of 30-day mortality (15). Restricted cubic splines were constructed to display the 
nonlinear association between these data. Adjusted analyses were not planned for this mainly 












patients as described in detail in the published study protocol (8). Analyses were done in 
Stata/IC 16.0, StatCorp, College Station, TX. 
 
Incidence rate estimation 
Population data of the Dutch Central Bureau of Statistics (www.cbs.nl) were used as 
denominator for the estimation of the incidence rate of severe TBI.(16) Numerators were 
based on inclusion data from 2015 to 2017, as all 4 Dutch HEMS operators were including 
patients, and a nearly complete coverage of patients with suspected severe TBI can be 
assumed in these three years (8). To estimate the incidence rate of confirmed TBI, we 
extrapolated the proportion of confirmed TBI from the patients who were followed-up for AIS 
scores to the total sample (i.e., 83.7% of patients with available AIS data had confirmed TBI, 
and we used this percentage as the best estimate for the percentage of confirmed TBI across 
the entire sample of included patients).  
 
Results 
Characteristics of study subjects: 
In total, data of 2,589 consecutive patients treated between February 2012 and December 
2017 were recorded and analyzed. Among these patients 2,117 (81.8%) were transferred to a 















The incidence rate of suspected severe TBI was 3.2 (95% CI: 3.1; 3.4) per 100,000 inhabitants 
per year, based on a population average of 16,987,118 inhabitants and an average number of 
543 patients per year (2015-2017). For confirmed severe TBI, the estimated annual incidence 
rate was 2.7 (95% CI: 2.5; 2.8) patients per 100,000 population.  
 
Patient Characteristics 
Included patients ranged in age between 1 and 97 years (median 46 (24, 65) years), and 
1,827/2,580 were male (70.8%). Age distribution was bimodal with an early peak during 
adolescence (females) or young adulthood (males) and a second peak at around 50-80 years 
(both genders, Supplementary Figure 2).  
Preinjury American Society of Anesthesiologists (ASA) physical status scores were available 
for 1,692 of the patients transported to one of the participating trauma centers. Of these 
patients, 1017 (60.1%) had an ASA score of I, indicating no pre-injury systemic disease, 
while the others had some degree of pre-existing comorbidity, in particular arterial 
hypertension and cardiac disease (Table 1). The prevalence of preinjury anticoagulant drug 
use, including antiplatelet drugs, low-molecular weight heparin and vitamin K antagonists, 














HEMS crews attended to the incident with the helicopter in 1,989/2,586 (76.9%) of cases, and 
by road due to operational considerations (short distance to incident location) or for technical 
and meteorological reasons in the remainder of cases.  
Median time from dispatch to arrival of the HEMS team at the scene was 18 (13, 23) minutes 
(n=2,268). Median on-scene time was 16.5 (11, 24) minutes (n=1,798) and median transport 
time to the hospital was 18 (12, 24) minutes (n=1,819). The total overall median time from 
HEMS dispatch to hospital arrival was 54 (43, 66) minutes (n=1,729). This may 
underestimate the actual prehospital run time, because HEMS were secondarily summoned by 
the ambulance at the scene in 19% of cases, and the actual time of ambulance dispatch was 
not recorded in our dataset. A sensitivity analysis including only primary dispatches in which 
the HEMS was dispatched together with the ambulance services showed identical median 
total prehospital run time and identical quartiles. The median air and road distances between 
the scene of the incident and the trauma center were 22.3 (10.3, 39.1) km (n=2,066) and 30.2 
(15.9, 50.4) km (n=2,069), respectively. A total of 329 patients (12.8%) were transported to 
the trauma center by helicopter, and the remaining patients were transported by ambulance 
(total n=2,567).  
 
Trauma and Injury Characteristics 
Figure 1 and Table 2 summarize the trauma mechanisms and injury characteristics.  
More than half of the patients were involved in road traffic crashes (58.4%, n=1,488/2,549). 












a helmet was observed in only 7.2% (40 cases) of bicycle crashes. Falls from height 
accounted for 35.4% cases. Violence and assaults were uncommon in our patient population 
(<2%). Results stratified by age (at median) and gender are shown in Figure 1.  
 
The first GCS scores recorded on arrival of the EMS are presented in Figure 2. Slightly less 
than half of the patients (47.6%) presented with an initial GCS of 3. In the remaining patients 
the GCS scores were approximately uniformly distributed between 4 and 8, except for 13 
patients who initially had a GCS >8 on first EMS contact but subsequently deteriorated to 8 or 
less during the prehospital phase.  
Injury Severity Score data were available from 1853 patients transported to participating 
trauma centers. Of these, 1,551 patients (83.7%, 95% CI: 81.9; 85.4%) had confirmed TBI 
(i.e., Head AIS ≥3), and 776 patients (50.0% of patients with confirmed TBI, 95% CI: 47.5; 
52.6%) had an isolated TBI without relevant extracranial injuries. The median Head AIS 
score was 4 (3, 5), and the median ISS score was 26 (20, 36), (Supplementary Figure 3). The 
Rotterdam and Marshall CT scores of the first CT after presentation at the Emergency 
Department are shown in Supplementary Figure 4).  
 
Outcome 
The overall 30-day mortality was 39.0% (95% CI: 36.8; 41.2, n = 1,985), for confirmed TBI 
42.4% (95% CI: 39.9; 44.9, n=1,547) and for isolated TBI 41.3% (95% CI: 37.8; 44.8, 












A higher patient age as well as increasing injury severity (initial GCS score, ISS score) were 
associated with a higher 30-day mortality (all p-values for linear trend <0.001; restricted cubic 
splines shown in figure 4).  
Overall mortality was 42.1% (95% CI: 39.8; 44.5, n=1,717) at 1 year. Figure 5 shows the 
Kaplan-Meier curve of survival during the 12-month follow up period. As can be seen, 
mortality mostly occured before day 10, and the curve flattened out after 30 days.  
Functional recovery of survivors at hospital discharge and at 1 year are shown in Figure 6. 
While most patients were discharged from hospital with severe disabilities (of those 
discharged alive and with available GOS data, 59% had a GOS of ≤3 at discharge), more than 
half of survivors had a good recovery at 1 year (52% with a GOS-E of 7 or 8).  
 
Discussion 
This article presents the first results of the BRAIN-PROTECT study, focusing on the 
epidemiology, prehospital characteristics, and outcomes of severe TBI in the Netherlands.  
During the study period, a total of 2,589 patients with prehospital suspicion of severe TBI 
were managed by one of the four HEMS. This corresponds to an annual incidence rate of 3.2 
per 100,000 inhabitants. The incidence rate of confirmed severe TBI was estimated as 2.7 per 
100,000 per year. In Europe, a wide variability of incidence rates has previously been 
reported. Across all TBI severities and ages, the reported incidence rates ranged from 47.3 to 
694 per 100,000 inhabitants per year (17), with an estimated pooled incidence rate of 262 per 












rate of 213.6/100,000 (4) and observed that only approximately 1% of TBI patients have 
severe TBI (19). Taken together, this suggests that the expected annual incidence rate of 
severe TBI should be somewhere around 2.1 (previous Dutch studies) to 2.6 (pooled 
European data)/100.000 in the Netherlands, which is very close to and consistent with the 
estimate in our study. Only few other studies have specifically investigated the incidence rate 
of severe TBI. Masson et al reported an annual incidence rate of 17.3/100,000 in France in 
1996 (20), and Andelic et al observed incidence rates of 5.2/100,000 in 2009 and 4.1/100,000 
in 2010 in Norway (21). It is unclear whether the differences to our data reflect true 
differences between countries, whether developments in primary prevention may have led to a 
general decrease of the incidence rate of severe TBI over time, or whether it was simply 
attributable to different methods to define TBI and to identify patients.  
The patient characteristics of our population were similar to those reported in previous 
studies. The majority of patients with severe TBI were male, which is likely to be at least 
partially due to a higher risk propensity in men compared to women (22, 23). Also consistent 
with previous literature (24), the median age was around 45 years in our patients, indicating 
that many patients are quite young. In fact, 74% were younger than 65 years – which is the 
current but dynamically changing retirement age in the Netherlands – indicating that severe 
TBI often affects the economically most relevant part of society. Costs of TBI have 
previously been estimated to be as high as €314.6 (currently about USD $370.8) million per 
year in the Netherlands (4). Especially the rather young, healthy and working adults 












associated with the trauma, but also in particular due to long term and indirect costs due to 
loss of productive life years, inability to work, as well as lifetime care. Hence, our data 
support that severe TBI is not only a serious medical condition but also a relevant economic 
factor in the Netherlands. 
 
Previous studies including all TBI severities often described a trimodal age distribution with 
peaks at early childhood, late adolescence/early adulthood and in the elderly (25). In our 
population of severe TBI patients, the age distribution was bimodal and without a peak in 
early childhood. Less than 4% of patients were below age 10, suggesting that severe TBI is 
rare among infants, toddlers and young children in the Netherlands. Interestingly, the location 
of the early age peak differed between females (at adolescence) and males (at young 
adulthood). This may suggest that measures targeted at primary prevention of TBI of certain 
age groups may also need to take into account the gender of those to be protected.  
 
Slightly more than half of the patients had no relevant comorbidities, which can be explained 
by the fact that many patients were relatively young. However, this also means that a relevant 
proportion of patients – especially those at advanced age - did have more or less severe 
comorbidity: of those older than 65 years, almost 80% had comorbidities such a chronic 
hypertension, which in turn, may shift the cerebral autoregulation curve and affect cerebral 
perfusion after TBI, with adverse effects on eventual outcome. Likewise, patients with cardiac 












Importantly, the overall prevalence of anticoagulant drug use – which can significantly 
aggravate intra- and extracranial hemorrhage – was 14%, and this increased to about 50% in 
patients older than 65 years. While emergency healthcare providers – from our experience – 
may have the tendency to focus on the trauma itself, these observations reinforce that 
treatment often also needs to consider chronic comorbidities and medications, in particular in 
the elderly. 
 
Similar to previous reports (25), road traffic crashes were a major mechanism of injury in our 
patients, followed by falls. Cycling is popular among all ages in the Netherlands, and so not 
surprisingly, cyclists were involved in a major proportion of traffic related injuries, in up to 
53.6% of traffic related cases in patients older than 45 years.In contrast to other European 
countries, commuter cyclists in the Netherlands rarely use cycling helmets (in our sample 
only 7.2% of bicyclists used a helmet). The high proportion of cycling related TBI which we 
observed suggest that not only general attempts to improve traffic safety but also attempts in 
particular to increase bicycle helmet use might play a pivotal role in the primary prevention of 
severe TBI in the Netherlands.  
 
Among the falls, about 7% were because of a suicide attempt, and a few due to assault, but the 
vast majority were trauma incidents occurring at home or at work. This suggests the potential 
for improvements in private and occupational safety with respect to fall prevention. In 












be at risk of falling. In fact, falls accounted for about 50% of TBI cases in patients older than 
65 years. While we did not explicitly record the percentage of patients who have fallen down 
stairs, we are aware that this is a major contributor. All other trauma mechanisms were of far 
lesser importance, suggesting that resources for primary prevention of TBI should primarily 
be directed at traffic and fall prevention. In particular, our data hightlighted differences in 
trauma mechanisms depending on patient age, which should be considered for primary 
prevention strategies.  
 
The Netherlands is a rather small, densely populated and well-developed country, with 
relative short distances to trauma centers (mean distance over the road of 30km). This differs 
from many other geographical regions and may explain the low rate of helicopter transported 
patients (12.8%) versus ground ambulance patients. HEMS response times and prehospital 
treatment times seemed reasonable, with a median total prehospital run time of less than 1 
hour for primary HEMS missions. Nonetheless, further improvements may be possible and 
(H)EMS operators as well as prehospital healthcare providers should critically reevaluate their 
procedures and determine whether time can be saved in the prehospital trajectory. 
 
Our data show that most mortality after severe TBI occurred within 10 days and only few 
patients died after 30 days, suggesting that once patients survived up to this time point, they 
had a good chance of becoming long-term survivors. This may not only be prognostically 












aware from own experience that long-term follow up of a large number of patients is quite 
challenging, and the data demonstrated that 30-day mortality is a useful surrogate for long 
term mortality in TBI research. Of those who survived until one year, more than 50% 
experience good recovery as indicated by a score of 7 (lower good recovery) or 8 (upper good 
recovery) in the GOS-E score obtained during a structured interview. (26) These scores 
indicate that a majority of survivors can function independently and resume normal life 
activities with either no (GOS-E=8) or only minor problems such as concentration or memory 
deficits (GOS-E=7) affecting daily life. Telephonic assessment of the GOS-E by a well-
trained datamanager has been demonstrated as a valid alternative for face-to-face assessment 
(27).  
 
Similar to reported incidence estimates, the reported mortality after TBI varies widely across 
literature (28-30). The thirty day mortality of 39% and 1-year mortality of 42% which we 
observed was lower than the 47% mortality for HEMS treated patients reported by 
Franschman et al in a previous Dutch study with comparable patients (GCS <9, but only 
patients ≥16 years were included) using data from 2008-2009 (31). It is possible that this 
difference reflects a general improvement in TBI survival within the last decade, but sampling 
variability and differences in patient selection and follow-up cannot be excluded. In this 
study, we only did a cursory analysis of associations of factors and mortality, in particular, to 
determine the validity of the data and to test whether the previously described and well-












hold in our dataset (1, 24, 32, 33). As expected, significant relationships were observed. 
Future studies using the BRAIN-PROTECT dataset will look with much more detail into the 
adjusted relationships between demographic factors, prehospital characteristics, treatments 
and outcomes.  
 
The BRAIN-PROTECT study is subject to the inherent limitations of observational studies 
and does not allow causal inferences on relationships between treatment related factors and 
outcomes (8). This is less of a concern in this present study, which primarily aimed to 
describe prehospital characteristics and the epidemiology of severe TBI in the Netherlands.  
 
To minimize selection bias, all consecutive patients with prehospital suspicion of severe TBI 
were included. As severe TBI is a primary dispatch criterion for HEMS in the Netherlands 
(34), we expected that we would have included the vast majority of patients, allowing a useful 
estimate of the incidence rate of potentially treatable severe TBI. Nonetheless, we may have 
missed a few patients, e.g., due to unavailability of HEMS or due to a a quick transport of 
patients when the trauma occurred in close proximity of a treatment hospital. 
 
We did not include patients who were declared dead at the incident scene but only patients 
admitted to a trauma center, and the reported incidence rate therefore underestimates the true 
incidence rate of severe TBI. However, previous studies reporting epidemiologic data also 












(17, 18, 25), which facilitates a comparison of our data to previous literature. Importantly, 
while our data could not estimate the overall incidence rate, the incidence rate that we 
reported actually represents the clinically more relevant estimate of the incidence rate of 
potentially treatable severe TBI – i.e., the number of patients that may have benefit from 
optimal prehospital treatment.  
 
In summary, this article reports the prehospital characteristics and epidemiology of severe 
TBI in the Netherlands. The data allowed the most recent estimate of the incidence of severe 
TBI and set the framework for future BRAIN-PROTECT studies aiming to identify beneficial 
treatment strategies for this patient population. Moreover, the data may have implications for 
resource allocation in primary prevention, for the treatment of patients with comorbidities, 
and for future TBI research. 
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Figure 1 “Trauma Mechanism” 
Pie chart of the distribution of trauma mechanisms (right panel) and percentages stratified by 















Figure 2 “Distribution of first GCS” 
Bar chart presenting the distribution of first measured GCS scores on scene, stratified by 
subgroup ( “all patients”, “confirmed TBI” and “isolated TBI”). Actual numbers (n) of cases 














Figure 3 “Distribution of 30-day mortality” 
Proportions and 95% confidence intervals of mortality per anonymized trauma center and per 














Figure 4 “Association between Age , GCS & ISS and Mortality Probability” 















Figure 5 “Survival curve” 















Figure 6 “Functional recovery of survivors” 
Bar chart presenting the distribution of the Glasgow Outcome Scale (GOS) scores at 
discharge and the Extended Glasgow Outcome Scale (GOS-E) scores at +/- 12 
months. Data are presented for the three subgroups, i.e. “all patients”, “confirmed 
TBI” and “isolated TBI”. Actual numbers (n) of cases per category of GOS & GOS-E 













Table 1 Pre-injury condition of patients 
Pre-Injury ASA classification 
 n %*  
ASA 1: Healthy patient 1,017 60.1  
ASA 2: Patient with mild systemic disease 458 27.1  
ASA 3: Patient with severe systemic disease 197 11.6  
ASA 4: Patient with severe systemic disease and constant threat to life 20 1.2  
 
* Percentage based upon ASA pre-injury data retrieved in 1692 patients. 
 
 




 Hypertension 194  (1,512) 
 Cardiac diseases 179  (1,504) 
 Pulmonary diseases 113  (1,514) 
 Diabetes 113  (1,522) 
 Neurological diseases 96  (1,493) 
 Renal diseases 4  (1,508) 
±













Table 2 Injury characteristics 
 
 Overall 
Dominant type of injury n % 
Blunt 2,465 95.2 
Penetrating 52 2.0 
Combined blunt/penetrating injury 24 0.9 
Unknown 48 1.9 
   
Intention of injury   
Accidental 2,329 90.0 
Self-inflicted 116 4.5 
Assault 47 1.8 
Other 3 0.1 
Unknown 94 3.6 
   
Location of injury   
Road 1,583 61.1 
Workplace 135 5.2 
Home 604 23.3 
Sport Facility 46 1.8 
Other 121 4.7 
Unknown 100 3.9 
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